Cite
HARVARD Citation
Mukae, H. et al. (2023). Efficacy and Safety of Ensitrelvir in Patients With Mild-to-Moderate Coronavirus Disease 2019: The Phase 2b Part of a Randomized, Placebo-Controlled, Phase 2/3 Study. Clinical infectious diseases. pp. 1403-1411. [Online].